Notice of Change: Early Expiration of NOT-NS-22-095: HEAL Initiative Notice of Special Interest (NOSI): Development and Validation of Pain-Related Models and Endpoints to Facilitate Non-Addictive Analgesic Discovery
Notice Number:
NOT-NS-24-100

Key Dates

Release Date:

May 15, 2024

Related Announcements

  • July 14, 2022 - HEAL Initiative Notice of Special Interest (NOSI): Development and Validation of Pain-Related Models and Endpoints to Facilitate Non-Addictive Analgesic Discovery. See Notice, NOT-NS-22-095.
  • March 12, 2021 - Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed). See NOFO, PAR-21-123.

Issued by

National Institute of Neurological Disorders and Stroke (NINDS)

Purpose

The purpose of this Notice is to inform the extramural community that NOT-NS-22-095: "HEAL Initiative Notice of Special Interest (NOSI): Development and Validation of Pain-Related Models and Endpoints to Facilitate Non-Addictive Analgesic Discovery", will be expired as of October 22, 2024. 

The following section of NOT-NS-22-095 has therefore been modified:

Currently Reads:

Part 1. Overview Information

Key Dates

Release Date:July 14, 2022
First Available Due Date:October 18, 2022
Expiration DateJune 25, 2025


Modified to Read (key change shown in bold italics to indicate early expiration and removal of remaining receipt dates):

Part 1. Overview Information

Key Dates

Release Date:July 14, 2022
First Available Due Date:October 18, 2022
Expiration DateOctober 22, 2024

All other aspects of this NOFO remain unchanged.

Inquiries

Please direct all inquiries to:

Rebecca Roof, PhD
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-1779
Email: rebecca.roof@nih.gov

Julia L Bachman, PhD
National Institute of Neurological Disorders and Stroke (NINDS)
Email: julia.bachman@nih.gov